Cagrilintide 30mg — Vial Spec, Reconstitution Math & COA

30mg Vial Specifications & Laboratory Utility Overview

A 30mg vial of Cagrilintide provides a high-yield unit of lyophilized peptide engineered for extensive laboratory research applications. Cagrilintide is a long-acting synthetic acylated amylin analogue designed to target both calcitonin receptors (CTR) and amylin receptors (AMYR1, AMYR2, and AMYR3). In preclinical research protocols, high-mass vial formats like the 30mg configuration are primarily selected by high-throughput screening facilities, bioanalytical assay laboratories, and academic teams conducting long-term rodent cohort studies requiring uniform batch consistency across multiple testing dates.

While PX1 Research routinely provides standardized high-purity research units—including our flagship single-unit Cagrilintide research compound—high-mass requests such as 30mg formats are frequently evaluated for bulk analytical runs. If a specific 30mg single-vial unit is not currently listed in our standard online inventory, researchers can inspect our full catalog of research peptides or request custom bulk filling via our wholesale lab accounts infrastructure. Utilizing a single 30mg mass lot minimizes inter-vial variation, simplifying serial dilution workflows and maintaining tight experimental controls.

Molecular Profile & Dual Amylin/Calcitonin Receptor Agonism

Cagrilintide features a modified peptide backbone derived from native human amylin, augmented with specific amino acid substitutions and a fatty acid diacid moiety. This structural modification allows non-covalent binding to serum albumin in animal models, significantly extending its plasma half-life compared to native amylin. In vitro binding assays demonstrate that Cagrilintide acts as a non-selective, high-affinity full agonist at human and rodent amylin receptors (AMYR1–3) as well as the calcitonin receptor (CTR).

Preclinical studies suggest that central activation of AMYR and CTR pathways modulates nutrient intake, gastric emptying kinetics, and satiety signals within the area postrema and nucleus of the solitary tract. In animal models, Cagrilintide administration has demonstrated significant weight regulation and metabolic modulation independently of incretin pathways. The dual activation profile makes this compound an essential tool for investigating non-incretin pathways in metabolic research.

Reconstitution Math & Concentration Profiles for 30mg Vials

Reconstitution of a high-mass 30mg lyophilized cake requires precise volumetric calculation to maintain desired working concentrations and prevent accidental precipitation. Due to the higher mass of peptide solute, researchers must carefully select the volume of Bacteriostatic Water (0.9% benzyl alcohol) or sterile diluent added to the vial. Researchers can verify exact liquid displacement calculations using our interactive reconstitution calculator.

The mathematical relationship between added diluent volume ($V$) and final peptide concentration ($C$) follows the standard equation $C = \frac{M}{V}$, where $M = 30\text{ mg}$:

• Reconstitution with 1.0 mL Diluent: Yields a concentration of 30.0 mg/mL (30.0 µg/µL). This high-density working stock is ideal for micro-volume microplate assays or compact storage, though thorough visual inspection is required to ensure total solubilization.

• Reconstitution with 2.0 mL Diluent: Yields a concentration of 15.0 mg/mL (15.0 µg/µL). This balanced concentration balances ease of pipetting with minimal volume displacement for automated dispensing systems.

• Reconstitution with 3.0 mL Diluent: Yields a concentration of 10.0 mg/mL (10.0 µg/µL). This standard metric concentration simplifies calculations for bench researchers performing serial dilutions down to sub-micromolar experimental ranges.

Aliquot Planning & Lab Handling for High-Mass Lyophilized Vials

When handling a 30mg reconstituted peptide stock, repeated freeze-thaw cycles can induce physical degradation, aggregation, or peptide cleavage. To preserve the integrity of the secondary structure, laboratory protocols should enforce an aliquot plan immediately following initial solubilization.

Once the lyophilized cake is fully dissolved by gently swirling—never vortexing—the solution, the primary stock should be divided into single-use low-binding polypropylene microcentrifuge tubes. Aliquot sizes should be calculated based on daily assay requirements (e.g., 50 µL or 100 µL micro-aliquots). Flash-freeze these working aliquots at -80°C or store them short-term at 2°C to 8°C depending on experimental timelines. This approach minimizes mechanical shear and thermal stress on the molecular chain.

Comparative Analytical Profile: Cagrilintide vs. Incretin Mimetics

In metabolic preclinical research, Cagrilintide is frequently evaluated alongside or in combination with single- and multi-receptor incretin mimetics. Understanding the mechanistic differences between these distinct chemical classes is essential for designing robust comparative trial protocols.

While Cagrilintide operates via amylin and calcitonin receptor pathways, compounds such as Semaglutide act exclusively as selective GLP-1 receptor agonists. Multi-incretin research compounds, such as the dual GLP-1/GIP agonist Tirzepatide and the triple GLP-1/GIP/Glucagon agonist Retatrutide, engage metabolic cascades through distinct signaling pathways. Preclinical rodent models investigating combination regimens (e.g., co-administration of an amylin agonist with a GLP-1 receptor agonist) demonstrate synergistic reductions in food intake and body mass compared to monotherapy protocols, underscoring the value of comparing these separate peptide categories in vitro and in vivo.

Analytical Quality Standards: HPLC, MS, and Endotoxin Verification

Maintaining rigorous quantitative controls is necessary for reproducible preclinical data. Every lot of peptide synthesized for PX1 Research undergoes strict analytical characterization in an ISO 17025 accredited laboratory to verify identity, purity, and safety profiles.

Purity is assessed via High-Performance Liquid Chromatography (HPLC), guaranteeing that active peptide purity meets or exceeds 99.0%. Mass confirmation is performed using Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular weight matching the theoretical sequence mass. Additionally, because bacterial lipopolysaccharides can disrupt sensitive cell assays and animal inflammatory markers, every batch undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below standard research limits (<0.5 EU/mg). Researchers can access full documentation by entering their vial lot number on our lot-specific Certificate of Analysis portal.

Optimal Storage Conditions & Stability Metrics

Lyophilized Cagrilintide exhibits high stability when maintained under controlled environmental conditions. Upon arrival at the research facility, un-reconstituted 30mg vials should be stored in a commercial freezer at -20°C or colder, protected from light exposure and humidity. Desiccant packs should be kept alongside stored vials to prevent moisture accumulation during temperature transitions.

Following reconstitution with sterile bacteriostatic water, liquid stability depends heavily on storage temperature. Reconstituted solutions stored at 2°C to 8°C maintain analytical stability for up to 28 days when preserved with appropriate antimicrobial preservatives. For long-term preservation of reconstituted stock, working aliquots must be stored at -80°C. Review our comprehensive peptide storage protocols for detailed guidance on environmental controls and chemical degradation vectors.

Selecting the Optimal Vial Mass: 5mg, 10mg, or 30mg Configurations

Choosing between smaller vial masses (such as 5mg or 10mg) and larger high-yield units (such as 30mg) depends on the scale and frequency of your laboratory protocol. Smaller mass units are optimal for exploratory assays, brief acute dose-response studies, or facilities without dedicated -80°C aliquot storage capabilities, as they limit potential waste from unused liquid stock.

Conversely, selecting a 30mg vial configuration is advantageous for high-throughput screening, multi-arm animal studies running concurrently, or long-term baseline trials. Utilizing a single 30mg vial eliminates lot-to-lot and vial-to-vial operational variances across a broad experimental window. Researchers evaluating high-volume protocol requirements can consult our team regarding custom fills and bulk lot reservations via our dedicated research library hub.